and pfplasmepsin2 amplification (≥1·5 copies), and the pfKelch13-580Y mutation, suggesting the emergence of triple-mutant P falciparum strains. Worryingly, a significant increase in the proportion of triple mutants between the treatment periods was recorded (figure). 
Emergence of

Plasmodium falciparum triple mutant in Cambodia
We share Mallika Imwong and colleagues' 1 concern regarding the spread of single-fit multidrugresistant Plasmodium falciparum malaria parasites along the borders of Cambodia-ie, to Thailand, Laos, and Vietnam. In 2016, in Cambodia, artesunate-mefloquine (ASMQ) replaced dihydroartemisininpiperaquine (DHA-PPQ) as the firstline treatment for uncomplicated P falciparum malaria. The rationale for this combination relies on evidence that parasites carrying markers of resistance both to artemisinin (pfKelch13-580Y mutant) and piperaquine (later associated with the amplification of pfplasmepsin2) 
